Blog Should Laboratory Developed Tests (LDTs) be available to the general population before they have been fully demonstrated to work? by CGI | Jun 15, 2022read more How can you spot fraudulently recruited COVIDera Hereditary Cancer Tests? by CGI | Jun 13, 2022read more Caris Life Sciences Pays Over $2.8 Million to Settle False Claims Act Allegations from Delay in Submission of Genetic Cancer Screening Tests by CGI | Jun 8, 2022read more Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks by CGI | Jun 2, 2022read more FDA Safety Communication for Patients and Healthcare Providers on NIPS by CGI | Apr 20, 2022read more FDA Control of Laboratory Developed Tests (LDTs) Building Momentum with VALID Act by CGI | Mar 16, 2022read more Natera and CareDx Fined Millions for False Advertising Associated with Inappropriate Marketing for Testing by CGI | Mar 15, 2022read more Natera Minimal Residual Disease (MRD) Test Value Questioned by City of Hope for Colorectal Cancer Patients by CGI | Mar 9, 2022read more
Should Laboratory Developed Tests (LDTs) be available to the general population before they have been fully demonstrated to work? by CGI | Jun 15, 2022read more
How can you spot fraudulently recruited COVIDera Hereditary Cancer Tests? by CGI | Jun 13, 2022read more
Caris Life Sciences Pays Over $2.8 Million to Settle False Claims Act Allegations from Delay in Submission of Genetic Cancer Screening Tests by CGI | Jun 8, 2022read more
Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks by CGI | Jun 2, 2022read more
FDA Safety Communication for Patients and Healthcare Providers on NIPS by CGI | Apr 20, 2022read more
FDA Control of Laboratory Developed Tests (LDTs) Building Momentum with VALID Act by CGI | Mar 16, 2022read more
Natera and CareDx Fined Millions for False Advertising Associated with Inappropriate Marketing for Testing by CGI | Mar 15, 2022read more
Natera Minimal Residual Disease (MRD) Test Value Questioned by City of Hope for Colorectal Cancer Patients by CGI | Mar 9, 2022read more